logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Samantha Thomas

University of Oklahoma Health Sciences Center
H指数:12
被引数:935

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

MLH1启动子高甲基化及其与生存结局的关联：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

Gynecologic Oncology
IF4.1
2026-07-010
PRE
Borden, Lindsay E.; Cosgrove, Casey M.; Washington, Christina R.; Thomas, Samantha M.; Haight, Paulina J.; Brown, Ashley; Powell, Kristina; Harsono, Adrian; Mullen, Margaret; Crafton, Sarah; Jackson, Amanda L.; Corr, Bradley R.; Wright, Jason D.; Konecny, Gottfried E.; Bae-Jump, Victoria L.; Podwika, Sarah E.; Smitherman, Carson; Maxwell, G. Larry; Backes, Floor J.; Pothuri, Bhavana; Ko, Emily M.; Arend, Rebecca C.; Thaker, Premal H.; Duska, Linda R.; Secord, Angeles Alvarez; Moore, Kathleen N.
Safeguarding Quality in Health and Medical Science Information Today

确保健康与医学科学信息当今的质量

Postgraduate Medicine
IF2.8
2026-04-090
OAAI
Scott C. Ratzan; Rebecca K. Ivic; Kenneth H. Rabin; Ruth M. Parker; Sara Rubinelli; Rafael Obregon; Lawrence O. Gostin; Michael G. Baker; Samantha Thomas; Don Nutbeam; Ilona Kickbusch; J. Gregory Payne; Vivianne Ihekweazu; Kirsten J. McCaffery; Richard L. Street; Sir Cary Cooper
ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery

ASO视觉摘要：ER阳性、HER2阴性乳腺癌腋窝手术的当代趋势，根据新辅助内分泌治疗、新辅助化疗或初始手术进行分层。

Annals of Surgical Oncology
IF3.5
2025-12-040
PRE
Sasha R. Douglas; Samantha M. Thomas; Akiko Chiba; Maggie L. DiNome; Gayle A. DiLalla; E. Shelley Hwang; Kendra Modell Parrish; Laura H. Rosenberger; Jennifer K. Plichta; Ton Wang; Astrid Botty van den Bruele
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability

子宫内膜癌中lenvatinib与pembrolizumab联合应用的评估；一项关于实践模式、有效性和耐受性的真实世界多机构回顾。

gynecologic oncology
IF4.1
2025-08-140
PRE
Bradley R. Corr; Samantha M. Thomas; Paulina J. Haight; Elizabeth Stock; Jessica Floyd; Lindsay E. Borden; Irina Tunnage; Angeles Alvarez Secord; Rebecca Arend; Amanda L. Jackson; Jason D. Wright; Gottfried Konecny; Tara Castellano; Emily Ko; Sarah Podwika; Floor Backes; Daniel Spinosa; Margaret Mullen; Christina Washington; Bhavana Pothuri; Carson Smitherman; Alfonsus Adrian Hadikusumo Harsono; Hanaa Khadraoui; Yukio Suzuki; Ritu Salani; Kristina Powell; Shalini Subbarao; Stephanie Gaillard
Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype

新辅助化疗与肿瘤亚型无关，对化生性乳腺癌的总生存期无改善作用。

Annals of Surgical Oncology
IF3.5
2025-07-290
PRE
Ellery H. Reason; Samantha M. Thomas; Tori Chanenchuk; Astrid M. Botty van den Bruele; Maggie L. DiNome; E. Shelley Hwang; Kendra Modell Parrish; Ton Wang; Jennifer K. Plichta; Alexandra Thomas; Akiko Chiba; Laura H. Rosenberger
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study

基因组改变、分子靶向治疗与生存：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-05-010
PRE
Secord, Angeles Alvarez; Bae-Jump, Victoria; Backes, Floor; Thaker, Premal; Gehrig, Paola A.; Previs, Rebecca A.; Borden, Lindsay; Thomas, Samantha M.; Jackson, Amanda; Konecny, Gottfried E.; Duska, Linda R.; Arend, Rebecca; Wright, Jason; Corr, Bradley; Maxwell, G. Larry; Cosgrove, Casey M.; Mullen, Maggie M.; Washington, Christina; Herzog, Thomas J.; Cohen, Joshua; Hou, June; Gaillard, Stephanie; Fader, Amanda Nickles; Berchuck, Andrew; Pothuri, Bhavana
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

无铂间期及对复发性子宫内膜癌患者铂类再治疗或lenvatinib/pembrolizumab的应答：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

gynecologic oncology
IF4.1
2025-03-010
PRE
Haight, Paulina J.; Sanchez, Marilyn; Thomas, Samantha M.; Smitherman, Carson; Cosgrove, Casey; Bae-Jump, Victoria; Crafton, Sarah; Hacker, Kari; Ko, Emily; Krivak, Thomas; Lara, Olivia; Moore, Kathleen; Mullen, Mary M.; Pothuri, Bhavana; Thaker, Premal H.; Washington, Christina; Arend, Rebecca; Corr, Bradley; Duska, Linda; Jackson, Amanda; Konecny, Gottfried E.; Wright, Jason; Secord, Angeles; Backes, Floor

研究方向

暂未获取到该数据
J
Jennifer K. Plichta
H 指数:32论文数:245被引数:4,002
A
Akiko Chiba
H 指数:21论文数:161被引数:1,523
L
Laura H. Rosenberger
H 指数:32论文数:182被引数:5,626
J
Ji Won Park
H 指数:54论文数:567被引数:1.2万
T
Ton Wang
H 指数:16论文数:125被引数:1,183
B
Barbora Piknova
H 指数:29论文数:118被引数:2,418
M
Michael G. Baker
H 指数:65论文数:559被引数:1.7万
R
Ruth M. Parker
H 指数:0论文数:7被引数:0
A
Astrid Botty van den Bruele
H 指数:11论文数:87被引数:403
L
Lawrence O. Gostin
H 指数:85论文数:1,297被引数:3.0万